Using digital technology to improve diabetes care
Official title: Innovative Approaches in Diabetes Care
Run by Taipei Medical University · NCT05687968 · Data updated 2026-11-12
This study is testing whether using a mobile app for diet tracking can help people with diabetes in Taiwan manage their condition better than traditional nutrition education.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 39 (estimated) |
| Sponsor | Taipei Medical University Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | October 19, 2022 |
| Main results expected | October 1, 2025 |
| Study ends | October 1, 2025 |
| Registry record updated | July 30, 2025 |
| Trial ID | NCT05687968 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Taiwanese individuals aged 20 and older with pre-diabetes or diabetes who can use a smartphone.
✕Probably not a fit
Patients with eating disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of digital health technology in managing diabetes among patients in Taiwan. It involves recruiting 300 diabetic patients who will be randomly assigned to either a control group receiving conventional nutrition education or an experimental group utilizing a mobile application for dietary assessment and feedback. The intervention includes innovative tools like 3D/AR MetaFood for nutrition education, aiming to enhance dietary habits and lifestyle changes over a 12-month follow-up period. The study seeks to determine the long-term impacts of eHealth care on diabetes management.
Why it matters
Potential benefit: If successful, this approach could significantly improve dietary management and health outcomes for diabetic patients.
How similar studies have gone: Other studies have shown promising short-term results with digital health interventions for diabetes, but long-term effects remain largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 20 years old or older 2. Pre-diabetes or diabetes 3. Taiwan nationality or fluent in Mandarin or Taiwanese 4. Not pregnant or breastfeeding 5. Capable (or assisted by a caregiver) of using a smartphone to photograph and record meals Exclusion Criteria: 1. Eating disorders 2. Undergoing treatment for severe illnesses that could affect normal dietary intake (e.g., cancer) 3. Unable to use a smartphone to take photos and record food intake.
Where it's running
-
Jung-Su Chang
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Jung-Su Chang, PhD. — College of Nutrition, Taipei Medical University
- Study coordinator: Jung-Su Chang, PhD.
- Email: susanchang@tmu.edu.tw
- Phone: 886-66382736
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.